More on: mild hemophilia A and inhibitor development

被引:8
作者
Koestenberger, M
Leschnik, B
Muntean, W
机构
[1] Graz Univ, Kinder & Jugendpsychiat Klin, Dept Pediat, A-8036 Graz, Austria
[2] Graz Univ, Ludwig Boltzmann Res Inst Pediat Haemostasis & Th, A-8036 Graz, Austria
关键词
D O I
10.1111/j.1538-7836.2004.00677.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:676 / 676
页数:1
相关论文
共 7 条
[1]  
Hay CRM, 1998, THROMB HAEMOSTASIS, V79, P762
[2]  
Koestenberger M, 2000, HAEMOPHILIA, V6, P120
[3]  
MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991
[4]  
MCMILLAN CW, 1988, BLOOD, V71, P344
[5]   Induction of immune tolerance in haemophilia A inhibitor patients by the 'Bonn protocol': Predictive parameter for therapy duration and outcome [J].
Oldenburg, J ;
Schwaab, R ;
Brackmann, HH .
VOX SANGUINIS, 1999, 77 :49-54
[6]  
SANTAGOSTINO E, 1995, THROMB HAEMOSTASIS, V74, P619
[7]   Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A [J].
Sharathkumar, A ;
Lillicrap, D ;
Blanchette, VS ;
Kern, M ;
Leggo, J ;
Stain, AM ;
Brooker, L ;
Carcao, MD .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (06) :1228-1236